Medicinal products for the alimentary tract and metabolism | Tenderlake

Medicinal products for the alimentary tract and metabolism

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
21 August 2023
Closing Date:
19 September 2023
Location(s):
LT LIETUVA (LT Lithuania/LIETUVA)
Description:
Gastrointestinal and metabolic medicines — enzymes for the treatment of mucopolysaccharidosis type VI (Galsulfase)

The contracting authority intends to procure enzymes for the treatment of mucopolysaccharidosis type VI (Galsulfase), which affect the gastrointestinal tract and metabolism. The requirements for the subject-matter of the contract are set out in Annex 2 "Technical specification" to the HS (hereinafter referred to as the "Technical Specification" ('Annex 2 to the HS')).

The contracting authority intends to procure enzymes for the treatment of mucopolysaccharidosis type VI (Galsulfase), which affect the gastrointestinal tract and metabolism. The requirements for the subject-matter of the contract are set out in Annex 2 "Technical specification" to the HS (hereinafter referred to as the "Technical Specification" ('Annex 2 to the HS')).

Download full details as .pdf
The Buyer:
Valstybinė ligonių kasa prie Sveikatos apsaugos ministerijos
CPV Code(s):
33610000 - Medicinal products for the alimentary tract and metabolism